SEC Form D · filed February 16, 2022
Starton Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Cidnee Vaykovich · Paramus, NJExec · DirectorMohamad Hussein · Paramus, NJDirectorNitin Kaushal · Paramus, NJDirectorEric Baum · Paramus, NJDirectorKeith Darragh · Paramus, NJExecPedro Waisman · Paramus, NJExec · DirectorFotios Plakogiannis · Paramus, NJDirectorKenneth Anderson · Paramus, NJDirectorRoy Waldron · Paramus, NJDirectorAsher Chanan-Khan · Paramus, NJDirectorChristopher R. Kaster · Austin, TXExecMaria R. Berkman · Austin, TXDirectorJulie Boardman · NEW YORK, NYExec · DirectorEileen Tanghal · New York, NYDirectorDavid Helling · Lumberton, TXDirectorBrian R. Smith · Austin, TXExec · DirectorRoman Medjanov · San Francisco, CADirectorMatthew Dabrowski · Dallas, TXDirectorVor Capital LLP · London, United KingdomDirectorAdam Berman · Austin, TXDirectorStephen Markscheid · Toronto, Ontario, CanadaDirectorJian Yang · Toronto, Ontario, CanadaExec · DirectorStephen Blum · Toronto, Ontario, CanadaExec · DirectorXiangrong Xie · Toronto, Ontario, CanadaExecNicolas Blitterswyk · Toronto, Ontario, CanadaDirectorYun "Wendy" Liu · Toronto, Ontario, CanadaDirectorRobert Van Duynhoven · Toronto, Ontario, CanadaDirectorStephanie Bird · Toronto, Ontario, CanadaDirectorSara Shackelford · Washington, Washington, D.C.DirectorSusan D. Loughran · Glenview, ILDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗